VERTEPORFIN for Polypoidal choroidal vasculopathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 210 adverse event reports in the FDA FAERS database where VERTEPORFIN was used for Polypoidal choroidal vasculopathy.

Most Reported Side Effects for VERTEPORFIN

Side Effect	Reports	%	Deaths	Hosp.
Visual acuity reduced	173	23.0%	0	3
Off label use	129	17.1%	1	1
Polypoidal choroidal vasculopathy	128	17.0%	0	5
Disease progression	115	15.3%	0	3
Age-related macular degeneration	90	12.0%	0	3
Retinal haemorrhage	70	9.3%	0	8
Product use in unapproved indication	57	7.6%	1	1
Choroidal neovascularisation	47	6.2%	0	3
Retinal detachment	42	5.6%	0	2
Subretinal fluid	42	5.6%	0	0
Detachment of retinal pigment epithelium	36	4.8%	0	0
Macular degeneration	33	4.4%	0	2
Cystoid macular oedema	26	3.5%	0	0
Drug ineffective	23	3.1%	0	0
Product use issue	21	2.8%	0	0